AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3
slide-4
slide-5

Sitacip M 50mg/500mg Tablet PR

Prescription Icon
Prescription Required

Marketer

Cipla Ltd

Salt Composition

Sitagliptin (50mg) + Metformin (500mg)

Overview Sitacip M 50mg/500mg Tablet PR

Diabetic patients with type 2 mellitus may find relief from elevated blood glucose levels with the dual-action formula of Sitacip M 50mg/500mg Tablet PR. This medication combines two active components to effectively manage blood sugar, thereby mitigating the risk of severe diabetic complications such as renal impairment and vision loss. Furthermore, it may lessen the probability of cardiovascular events like stroke or heart attack. Sitacip M 50mg/500mg Tablet PR can be administered independently or in conjunction with other antidiabetic therapies. Optimal results are achieved when combined with a balanced diet and regular physical activity. Dosage is tailored to individual needs, considering existing health conditions, blood sugar readings, and other concurrent medications. Consuming this medication with food minimizes gastrointestinal discomfort. Consistent daily dosing at the same time maximizes therapeutic benefits; discontinuation should only occur under medical supervision. Adherence to the prescribed diet and exercise plan is crucial for effective diabetes management, as lifestyle choices significantly impact glycemic control. Commonly reported side effects include nausea, vomiting, diarrhea, stomach upset, headache, and pharyngitis. Hypoglycemia is a potential adverse effect, especially when used alongside insulin or sulfonylureas; patients should be educated on its recognition and treatment. This medication isn't universally suitable. Prior to commencement, individuals with pre-existing hepatic, renal, or cardiac conditions, pancreatic issues, or significant alcohol consumption should inform their physician. Pregnant or lactating women should also seek medical counsel before initiating treatment. Potential drug interactions exist; comprehensive disclosure of all medications is essential to ensure patient safety. Alcohol consumption should be minimized due to its potential to further reduce blood glucose. Regular monitoring of renal function and blood glucose levels will be conducted by your doctor throughout the treatment course.

Primary Ingredients of Sitacip M 50mg/500mg Tablet PR

No text provided to rephrase.

Uses of Sitacip M 50mg/500mg Tablet PR

Managing type 2 diabetes

Major Benefits of Sitacip M 50mg/500mg Tablet PR:

Follow your doctor's instructions or consult the product label for proper administration. Take Sitacip M 50mg/500mg Tablet PR with a meal.

Common Side effects of Sitacip M 50mg/500mg Tablet PR:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Sitacip M 50mg/500mg Tablet PR:

Follow your physician's instructions or consult the product information leaflet for usage guidance. Administer Sitacip M 50mg/500mg Tablet PR with food.

How Sitacip M 50mg/500mg Tablet PR works:

Sitacip M 50mg/500mg tablets (PR) combine sitagliptin and metformin to manage blood glucose. Sitagliptin boosts insulin production by the pancreas, enhances insulin utilization, and reduces hepatic glucose output. Metformin, a biguanide, decreases liver glucose production, slows intestinal glucose absorption, and improves insulin sensitivity. This dual action leads to superior glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining alcohol and Sitacip M 50mg/500mg Tablet PR is not advisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Sitacip M 50mg/500mg tablets during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice before taking this medication.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Sitacip M 50mg/500mg tablets during lactation is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Impaired driving is possible with both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Sitacip M 50mg/500mg Tablet PR, as dose modification may be necessary. Consult your physician for guidance. Sitacip M 50mg/500mg Tablet PR is contraindicated in patients exhibiting severe kidney disease. Close monitoring of renal function is recommended during treatment with this medication.

LiverLiverUNSAFE

Individuals with liver impairment should likely refrain from using Sitacip M 50mg/500mg tablets; the medication may pose unacceptable risks. Medical advice is recommended.

What if you forget to take Sitacip M 50mg/500mg Tablet PR :

Should you forget to take a Sitacip M 50mg/500mg Tablet PR, ingest it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your typical dosing regimen. Avoid taking a double dose.

Facts to Know About Sitacip M 50mg/500mg Tablet PR

LabelValue
Developing Habits No.
Type of Therapy Diabetes Management

FAQs on Sitacip M 50mg/500mg Tablet PR

Sitacip M 50mg/500mg tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Prolonged use of Sitacip M 50mg/500mg Tablet PR can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left untreated, may cause anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary difficulties, cognitive changes, and ataxia. To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Sitacip M 50mg/500mg Tablet PR may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can result in vitamin B12 deficiency.
Patients with known allergies to Sitacip M 50mg/500mg Tablet PR components or excipients, or those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis, should not use this medication.
Combining alcohol with Sitacip M 50mg/500mg Tablet PR is unsafe and may heighten the risk of lactic acidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Sitagliptin/Metformin (Sitacip M 50mg/500mg Tablet PR) can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also known as Metformin-associated lactic acidosis, or MALA). This rare side effect necessitates avoiding use in patients with kidney disease, the elderly, or those who consume significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Sitagliptin/Metformin and seek immediate medical attention.
Sitacip M 50mg/500mg Tablets are a dual-action treatment for type 2 diabetes in adults. Combining sitagliptin and metformin, it helps manage blood sugar levels when used with a healthy diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Sitacip M 50mg/500mg Tablet PR may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Patients with known allergies to Sitacip M 50mg/500mg Tablet PR components or excipients, or those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis should not use this medication.
Combining Sitacip M 50mg/500mg Tablet PR with alcohol is unsafe and may heighten the risk of lactic acidosis.
Sitagliptin/Metformin (Sitacip M 50mg/500mg Tablet PR) can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare side effect necessitates caution in patients with kidney disease, the elderly, or those consuming significant alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If experienced, discontinue Sitagliptin/Metformin and seek immediate medical attention.
Prolonged use of Sitacip M 50mg/500mg Tablet PR can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency may cause anemia, nerve damage (manifesting as numbness, tingling in extremities, weakness, and balance problems), and urinary issues, potentially impacting mental clarity. To mitigate these risks, annual vitamin B12 supplementation is recommended by some researchers.
Store this medication in its original, tightly closed container, as directed on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Sitacip M 50mg/500mg tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Sitacip M 50mg/500mg Tablet PR may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Patients allergic to Sitacip M 50mg/500mg Tablet PR components or excipients, or with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis, should not use this medication.
Combining alcohol and Sitacip M 50mg/500mg Tablet PR is unsafe due to the increased risk of lactic acidosis.
Sitagliptin/Metformin (Sitacip M 50mg/500mg Tablet PR) can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare side effect necessitates avoiding Sitagliptin/Metformin in patients with kidney disease, the elderly, or those who consume significant alcohol. Symptoms may include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Sitagliptin/Metformin and seek immediate medical attention.
Prolonged use of Sitacip M 50mg/500mg Tablet PR can lead to vitamin B12 deficiency by impairing its absorption in the stomach. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the packaging. Discard any unused medication and ensure it's kept out of reach of children, pets, and others.
Sitacip M 50mg/500mg Tabl...
103
MRP 120
14% off